Myocyte Enhancer Factor 2 and Class II Histone Deacetylases Control a Gender-Specific Pathway of Cardioprotection Mediated by the Estrogen Receptor-Reference-Cited by-同舟云学术

Myocyte Enhancer Factor 2 and Class II Histone Deacetylases Control a Gender-Specific Pathway of Cardioprotection Mediated by the Estrogen Receptor

Published:2010-01-08 Issue:1 Volume:106 Page:155-165
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circulation Research

Author:

van Rooij Eva¹,Fielitz Jens¹,Sutherland Lillian B.¹,Thijssen Victor L.¹,Crijns Harry J.¹,Dimaio Michael J.¹,Shelton John¹,De Windt Leon J.¹,Hill Joseph A.¹,Olson Eric N.¹

Affiliation:

1. From the Departments of Molecular Biology (E.v.R., J.F., L.B.S., E.N.O.), Cardiovascular and Thoracic Surgery (M.J.D.), Pathology (J.S.), and Internal Medicine (J.A.H.), University of Texas Southwestern Medical Center, Dallas; Department of Radiotherapy (V.L.T.), VU University Medical Center, Amsterdam, The Netherlands; and Department of Cardiology (H.J.C., L.J.D.W.), Maastricht University Medical Center, The Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference60 articles.

1. Emerging therapeutic targets in chronic heart failure: Part II

2. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

3. Molecular and Cellular Basis of Cardiovascular Gender Differences

4. The Protective Effects of Estrogen on the Cardiovascular System

5. Cell- and Ligand-specific Regulation of Promoters Containing Activator Protein-1 and Sp1 Sites by Estrogen Receptors α and β

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex difference in human diseases: mechanistic insights and clinical implications;Signal Transduction and Targeted Therapy;2024-09-10

2. m6A-mediated HDAC9 upregulation promotes particulate matter-induced airway inflammation via epigenetic control of DUSP9-MAPK axis and acts as an inhaled nanotherapeutic target;Journal of Hazardous Materials;2024-09

3. Epigenetic regulation of sex dimorphism in cardiovascular health;Canadian Journal of Physiology and Pharmacology;2024-09-01

4. Anti-ageing interventions for the treatment of cardiovascular disease;Cardiovascular Research;2024-08-22

5. Gender-specific genetic and epigenetic signatures in cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-03-11